Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Dapoxetine HCl belongs to a group of short-acting medicines called selective serotonin reuptake inhibitors (SSRIs). Dapoxetine drug is gaining popularity for the treatment of the most common problem in men, called premature ejaculation (PE). This medication marketed as Priligy...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
Negative marital interactions may increase the risk of cardiovascular disease by 8.5%, according to a new study by researchers from the University of Pittsburgh, PA.
Family history is a greater risk factor than lifestyle for developing some cancers, according to a Swedish study looking at 71,000 adopted people.
Despite an expansion in health care provision, a new study has found that the growth of health care expenditure in the US has slowed down over the past decade.